Ayurveda-Based Therapeutic Approaches in the Management of Symptomatic Adenomyosis: A Case Report

In: International Journal of AYUSH Case Reports · 2024 · vol. 8(4) , pp. 491–498 · doi:10.70805/ija-care.v8i4.649 · W4405636607
article OA: diamond CC0

Abstract

Adenomyosis is a clinical condition where there is ingrowth of the endometrium directly to the uterine myometrium. Symptoms of adenomyosis typically include menorrhagia, pelvic pain, and dysmenorrhea. Hysterectomy has been considered as definitive management for Adenomyosis. A 36-year-old obese female patient with regular cycles and moderate bleeding presented with severe dysmenorrhoea for the past 5 years. The pain was aching in nature, deep in the pelvis restricting her from doing day-to-day activities. She also had complaints of weight gain and fatigue, bloating of the abdomen, and whole-body pain premenstrually. The bimanual examination was suggestive of bulky uterus and pelvic USG was confirmative of Adenomyosis. As the patient presented with yonithoda (lower abdominal pain), gulma (bloated abdomen) and vankshana parswa vyatha (low back ache) it was considered as vathiki yoni vyapath. In this condition, the pain is predominantly due to vata dosha. The pitta kapha raktha pradhana sopha involved in the samprapthi of the disease also contributes to the pain. In this case, as the patient is obese, sthoulyahara chikitsa incorporated with vata anulomana and pitta,kapha,raktha samana was the treatment plan. The symptoms were gradually relieved by 3 months of treatment at the Department of Prasuti evam Stri Roga, Government Ayurveda College, Tripunithura, Ernakulam, Kerala.

My notes (saved in your browser only)

Condition tags

adenomyosisdysmenorrhea

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK